281 related articles for article (PubMed ID: 16002422)
1. Critical role for CCR5 in the function of donor CD4+CD25+ regulatory T cells during acute graft-versus-host disease.
Wysocki CA; Jiang Q; Panoskaltsis-Mortari A; Taylor PA; McKinnon KP; Su L; Blazar BR; Serody JS
Blood; 2005 Nov; 106(9):3300-7. PubMed ID: 16002422
[TBL] [Abstract][Full Text] [Related]
2. Differential roles for CCR5 expression on donor T cells during graft-versus-host disease based on pretransplant conditioning.
Wysocki CA; Burkett SB; Panoskaltsis-Mortari A; Kirby SL; Luster AD; McKinnon K; Blazar BR; Serody JS
J Immunol; 2004 Jul; 173(2):845-54. PubMed ID: 15240671
[TBL] [Abstract][Full Text] [Related]
3. An absence of CCR5 on donor cells results in acceleration of acute graft-vs-host disease.
Welniak LA; Wang Z; Sun K; Kuziel W; Anver MR; Blazar BR; Murphy WJ
Exp Hematol; 2004 Mar; 32(3):318-24. PubMed ID: 15003318
[TBL] [Abstract][Full Text] [Related]
4. L-selectin is dispensable for T regulatory cell function postallogeneic bone marrow transplantation.
Carlson MJ; Fulton LM; Coghill JM; West ML; Burgents JE; Wan Y; Panoskaltsis-Mortari A; Tedder TF; Blazar BR; Serody JS
Am J Transplant; 2010 Dec; 10(12):2596-603. PubMed ID: 21070606
[TBL] [Abstract][Full Text] [Related]
5. CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation.
Edinger M; Hoffmann P; Ermann J; Drago K; Fathman CG; Strober S; Negrin RS
Nat Med; 2003 Sep; 9(9):1144-50. PubMed ID: 12925844
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic bone marrow grafts with high levels of CD4(+) CD25(+) FoxP3(+) T cells can lead to engraftment failure.
Fricke S; Rothe K; Hilger N; Ackermann M; Oelkrug C; Fricke C; Schönfelder U; Niederwieser D; Emmrich F; Sack U
Cytometry A; 2012 Jun; 81(6):476-88. PubMed ID: 22522779
[TBL] [Abstract][Full Text] [Related]
7. Relationship between CCR5 and acute graft-versus-host disease in murine bone marrow transplantation.
Wang Z; Murphy WJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Oct; 14(5):934-40. PubMed ID: 17096892
[TBL] [Abstract][Full Text] [Related]
8. Chemokine receptor CCR5 mediates alloimmune responses in graft-versus-host disease.
Palmer LA; Sale GE; Balogun JI; Li D; Jones D; Molldrem JJ; Storb RF; Ma Q
Biol Blood Marrow Transplant; 2010 Mar; 16(3):311-9. PubMed ID: 20025985
[TBL] [Abstract][Full Text] [Related]
9. Extracorporeal photochemotherapy is accompanied by increasing levels of circulating CD4+CD25+GITR+Foxp3+CD62L+ functional regulatory T-cells in patients with graft-versus-host disease.
Biagi E; Di Biaso I; Leoni V; Gaipa G; Rossi V; Bugarin C; Renoldi G; Parma M; Balduzzi A; Perseghin P; Biondi A
Transplantation; 2007 Jul; 84(1):31-9. PubMed ID: 17627234
[TBL] [Abstract][Full Text] [Related]
10. The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality.
Taylor PA; Lees CJ; Blazar BR
Blood; 2002 May; 99(10):3493-9. PubMed ID: 11986199
[TBL] [Abstract][Full Text] [Related]
11. Post-hematopoietic cell transplantation control of graft-versus-host disease by donor CD425 T cells to allow an effective graft-versus-leukemia response.
Jones SC; Murphy GF; Korngold R
Biol Blood Marrow Transplant; 2003 Apr; 9(4):243-56. PubMed ID: 12720217
[TBL] [Abstract][Full Text] [Related]
12. Human CD8+ regulatory T cells inhibit GVHD and preserve general immunity in humanized mice.
Zheng J; Liu Y; Liu Y; Liu M; Xiang Z; Lam KT; Lewis DB; Lau YL; Tu W
Sci Transl Med; 2013 Jan; 5(168):168ra9. PubMed ID: 23325802
[TBL] [Abstract][Full Text] [Related]
13. Combined CXCR3/CCR5 blockade attenuates acute and chronic rejection.
Schnickel GT; Bastani S; Hsieh GR; Shefizadeh A; Bhatia R; Fishbein MC; Belperio J; Ardehali A
J Immunol; 2008 Apr; 180(7):4714-21. PubMed ID: 18354195
[TBL] [Abstract][Full Text] [Related]
14. L-Selectin(hi) but not the L-selectin(lo) CD4+25+ T-regulatory cells are potent inhibitors of GVHD and BM graft rejection.
Taylor PA; Panoskaltsis-Mortari A; Swedin JM; Lucas PJ; Gress RE; Levine BL; June CH; Serody JS; Blazar BR
Blood; 2004 Dec; 104(12):3804-12. PubMed ID: 15292057
[TBL] [Abstract][Full Text] [Related]
15. C-C chemokine receptor 5 and acute graft-versus-host disease.
Yuan J; Ren HY
Immun Inflamm Dis; 2022 Sep; 10(9):e687. PubMed ID: 36039647
[TBL] [Abstract][Full Text] [Related]
16. Granzyme B-Mediated Activation-Induced Death of CD4+ T Cells Inhibits Murine Acute Graft-versus-Host Disease.
Du W; Leigh ND; Bian G; O'Neill RE; Mei L; Qiu J; Chen GL; Hahn T; Liu H; McCarthy PL; Cao X
J Immunol; 2015 Nov; 195(9):4514-23. PubMed ID: 26392464
[TBL] [Abstract][Full Text] [Related]
17. Only the CD62L+ subpopulation of CD4+CD25+ regulatory T cells protects from lethal acute GVHD.
Ermann J; Hoffmann P; Edinger M; Dutt S; Blankenberg FG; Higgins JP; Negrin RS; Fathman CG; Strober S
Blood; 2005 Mar; 105(5):2220-6. PubMed ID: 15546950
[TBL] [Abstract][Full Text] [Related]
18. CD25 expression on donor CD4+ or CD8+ T cells is associated with an increased risk for graft-versus-host disease after HLA-identical stem cell transplantation in humans.
Stanzani M; Martins SL; Saliba RM; St John LS; Bryan S; Couriel D; McMannis J; Champlin RE; Molldrem JJ; Komanduri KV
Blood; 2004 Feb; 103(3):1140-6. PubMed ID: 12907445
[TBL] [Abstract][Full Text] [Related]
19. Alterations in chemokine receptor CCR5 expression on blood dendritic cells correlate with acute graft-versus-host disease.
Shahin K; Sartor M; Hart DN; Bradstock KF
Transplantation; 2013 Oct; 96(8):753-62. PubMed ID: 23903010
[TBL] [Abstract][Full Text] [Related]
20. CCR5 blockade combined with cyclosporine A attenuates liver GVHD by impairing T cells function.
Tang B; Ren H; Liu H; Shi Y; Liu W; Dong Y; Yin Y; Miao S
Inflamm Res; 2016 Nov; 65(11):917-924. PubMed ID: 27423909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
